메뉴 건너뛰기




Volumn 49, Issue 8, 2011, Pages 2884-2886

Collaborative evaluation of an erythromycin-clindamycin combination well for detection of inducible clindamycin resistance in beta-hemolytic streptococci by use of the CLSI broth microdilution method

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN;

EID: 79960970205     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00912-11     Document Type: Article
Times cited : (4)

References (12)
  • 1
    • 77952928356 scopus 로고    scopus 로고
    • Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin- clindamycin combinations
    • Bowling, J. E., et al. 2010. Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations. J. Clin. Microbiol. 48:2275-2277.
    • (2010) J. Clin. Microbiol. , vol.48 , pp. 2275-2277
    • Bowling, J.E.1
  • 2
    • 72949111486 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute. Approved standard, eighth edition, M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA
    • Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, eighth edition, M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
    • (2009) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically
  • 3
    • 33646696219 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute. Twenty-first informational supplement, M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA
    • Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement, M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
    • (2011) Performance Standards for Antimicrobial Susceptibility Testing
  • 4
    • 10844236221 scopus 로고    scopus 로고
    • Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: Implications for reporting susceptibility results
    • Desjardins, M., K. L. Delgaty, K. Ramotar, C. Seetaram, and B. Toye. 2004. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J. Clin. Microbiol. 42:5620-5623.
    • (2004) J. Clin. Microbiol. , vol.42 , pp. 5620-5623
    • Desjardins, M.1    Delgaty, K.L.2    Ramotar, K.3    Seetaram, C.4    Toye, B.5
  • 5
    • 36849054958 scopus 로고    scopus 로고
    • Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-hemolytic streptococci of Lancefield groups A, B, C, and G in Seville, Spain
    • Diaz, M., M. J. Torres Sanchez, and M. J. Aznar. 2008. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-hemolytic streptococci of Lancefield groups A, B, C, and G in Seville, Spain. Clin. Microbiol. Infect. 14:85-87.
    • (2008) Clin. Microbiol. Infect. , vol.14 , pp. 85-87
    • Diaz, M.1    Torres Sanchez, M.J.2    Aznar, M.J.3
  • 6
    • 0037083024 scopus 로고    scopus 로고
    • Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications
    • Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
    • (2002) Clin. Infect. Dis. , vol.34 , pp. 482-492
    • Leclercq, R.1
  • 7
    • 12144267967 scopus 로고    scopus 로고
    • Inducible clindamycin resistance in staphylococci: Should clinicians and microbiologists be concerned?
    • Lewis, J. S., II, and J. H. Jorgensen. 2005. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin. Infect. Dis. 40:280-285.
    • (2005) Clin. Infect. Dis. , vol.40 , pp. 280-285
    • Lewis II, J.S.1    Jorgensen, J.H.2
  • 8
    • 67349233039 scopus 로고    scopus 로고
    • Macrolide resistance in Streptococcus pyogenes: Prevalence, resistance determinants, and emm types
    • Michos, A. G., et al. 2009. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagn. Microbiol. Infect. Dis. 64:295-299.
    • (2009) Diagn. Microbiol. Infect. Dis. , vol.64 , pp. 295-299
    • Michos, A.G.1
  • 9
    • 33745249533 scopus 로고    scopus 로고
    • Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci
    • Raney, P. M., F. C. Tenover, R. B. Carey, J. E. McGowan, Jr., and J. B. Patel. 2006. Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci. Diagn. Microbiol. Infect. Dis. 55: 213-218.
    • (2006) Diagn. Microbiol. Infect. Dis. , vol.55 , pp. 213-218
    • Raney, P.M.1    Tenover, F.C.2    Carey, R.B.3    McGowan Jr., J.E.4    Patel, J.B.5
  • 10
    • 23844555181 scopus 로고    scopus 로고
    • Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003
    • Richter, S. S., et al. 2005. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41:599-608.
    • (2005) Clin. Infect. Dis. , vol.41 , pp. 599-608
    • Richter, S.S.1
  • 11
    • 53649088204 scopus 로고    scopus 로고
    • Streptococcus
    • P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), 9th ed. American Society for Microbiology, Washington, DC
    • Spellerberg, B., and C. Brandt. 2007. Streptococcus, p. 412-429. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 9th ed. American Society for Microbiology, Washington, DC.
    • (2007) Manual of Clinical Microbiology , pp. 412-429
    • Spellerberg, B.1    Brandt, C.2
  • 12
    • 78649605964 scopus 로고    scopus 로고
    • Prevention of perinatal group B streptococcal disease; revised guidelines from CDC, 2010
    • Verani, J. R., et al. 2010. Prevention of perinatal group B streptococcal disease; revised guidelines from CDC, 2010. MMWR Recomm. Rep. 59(RR-10):1-36.
    • (2010) MMWR Recomm. Rep. , vol.59 , Issue.RR-10 , pp. 1-36
    • Verani, J.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.